Sean Reilly, DAIC Publisher

Sean Reilly is healthcare brands group publisher (Imaging Technology News and Diagnostic and Interventional Cardiology) at Scranton Gillette Communications.
 

Blog | Sean Reilly, DAIC Publisher | January 09, 2013

Innovation Exasperation

In a recent LinkedIn Medical Device Group posting, it was noted that DuVal & Associates, P.A. filed a Citizen Petition and Petition for Stay of Action with the FDA, on behalf of the Minnesota Medical Device Alliance (MMDA). See: http://medgroup.biz/FDA-petition

The petition challenges the FDA's practices and interpretations for reviewing 510(k)s and asks the Commissioner to stay the implementation of “Draft Guidance: Evaluating Substantial Equivalence in Premarket Notifications [510(k)],” dated December 27, 2011. It seeks reversion to older guidance until FDA addresses:

Its practice of “stage-gating” reviews (because it leads to an inevitable FDA request to pursue the de novo path); Its interpretation of “general versus specific intended use,” now applied so narrowly that FDA considers almost every new indication for a 510(k) device to be a new intended use; Its interpretation of clinical utility/benefit as part of the substantial equivalence (SE) criteria (because it essentially allows FDA to determine which devices practitioners should use); Its inappropriate use of statutes and regulatory matters extraneous to the SE decision (e.g., cGMP/Quality Systems, MDR, FD&C Act advertising and promotion, and OSHA regulations or CDC guidance); Its application of risk mitigation and “assurance case” principles to 510(k) clearance criteria; Its interpretation when a device has a new technological characteristic which raises new questions of safety and effectiveness; Its failure in stage-gated reviews to review performance data to determine same intended use / technological characteristics and if new safety and effectiveness questions need to be asked; Its practice of dictating the non-clinical and clinical performance data an applicant must generate (instead of reviewing submitted data at face value for an SE decision); and, Its approach to “whistleblowing,” which can lead to risk-averseness for political, not safety, reasons.

 

The petition seems on the mark. Medical device companies are under enormous financial pressures with difficult economies both domestically and abroad. Add to this the 2.3% medical device tax on gross revenues and a highly bureaucratic, overbearing (if you agree with this petition) FDA and you can’t help but envision difficult times ahead for our industry. Innovative small and midsize companies are struggling, and the government and the FDA aren’t helping matters by treating innovation as the problem. Many on the device side seem unable or unwilling to challenge the FDA bureaucracy.  Win the battle but lose the war, perhaps? As one CEO recently shared, "Challenging [the FDA] might make me feel better but it won't resolve the problem." A real shame as, according to this petition, the FDA and some of its policies need to be challenged.

I agree with this petition that the United States may fall behind other countries in having access to state-of-the-art medical devices while they still are state-of-the-art. That ship may have already sailed, in fact. I also agree that innovation – something we have always embraced and encouraged as a great nation – is being thwarted rather than supported. Healthcare consumers and innovative device companies are suffering and will continue to do so if changes aren’t made. 

Despite said doom and gloom, some innovative, well-managed companies will blast through the aforementioned roadblocks and become stronger, particularly as competition drops off. But I’m concerned that it's going to be mostly the largest companies that survive, and innovation might not always be their strongest suit. I’m also concerned that, as competition disappears, medical device prices will increase – not good for consumers or our Healthcare System.

There is a symbiotic relationship between healthcare providers, healthcare consumers, device manufacturers, our government and the FDA. Sadly, the later have too much power and our system, as this petition suggests, is out of balance and in need of correction. If you agree, beat the drums!

Related Content

Digital mHealth advances like wearable heart monitors, use of smartphone apps and artificial intelligence will reshape the standard of care in the coming years according to three recent JACC articles.

Digital mHealth advances like wearable heart monitors, smartphone apps and artificial intelligence will reshape the standard of care in the coming years according to three recent JACC articles.

Feature | Information Technology | June 05, 2018
June 5, 2018 — The future of cardiovascular care will be transformed by advances in artificial intelligence, digital
Lumedx Demonstrates Advanced Analytics at HIMSS18
News | Information Technology | February 20, 2018
February 20, 2018 – LUMEDX Corporation, a top cardiovascular data intelligence company, will show off the latest in a
ACC Unveils Innovation Roadmap for Future of Healthcare Delivery, the future of cardiology.
News | Information Technology | January 09, 2018
In a new health policy statement, the American College of Cardiology (ACC) identifies how to best support healthcare...
Nuance Restores Service to Majority of eScription Clients Following Malware Incident
News | Information Technology | July 28, 2017
Nuance Communications Inc. provided an update on its restoration process following the previously reported June 27,...
News | Information Technology | May 11, 2017
McKesson Imaging & Workflow Solutions, an industry leader in providing healthcare IT and imaging solutions, is...
ECRI Institute, top 10 patient safety concerns, 2017 report, information technology, healthcare
News | Information Technology | March 24, 2017
Safe implementation of new technologies and therapies accompany classic patient safety challenges on ECRI Institute's “...
Frost & Sullivan, Healthcare Industry Outlook 2017 analysis, information technology, healthcare IT
News | Information Technology | March 08, 2017
Despite global political uncertainties and a sluggish economic outlook for 2017, the global healthcare industry is set...
Mercy, HIMSS 2017, Enterprise Davies Award, health information technology
News | Information Technology | February 21, 2017
Mercy, the fifth largest Catholic healthcare system in the nation, was named a 2016 Healthcare Information and...
Frost & Sullivan, 18 technologies, growth opportunities, global healthcare, information technology, 2025
News | Information Technology | January 16, 2017
Frost & Sullivan has released a new report, “Vision 2025 – Future of Healthcare,” part of the company’s Advanced...
ACC, American College of Cardiology, Google search, heart conditions, Health Knowledge Graphs
News | Information Technology | September 23, 2016
A Google search for heart conditions will now prominently display important questions patients should ask their doctor...
Overlay Init